144 related articles for article (PubMed ID: 34485122)
1. Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy.
Qin Y; Zhou J; Fan Z; Gu J; Li X; Lin D; Deng D; Wei W
Front Oncol; 2021; 11():683876. PubMed ID: 34485122
[TBL] [Abstract][Full Text] [Related]
2. Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma.
Hatogai K; Fujii S; Kojima T; Daiko H; Doi T; Ohtsu A; Ochiai A; Takiguchi Y; Yoshino T
BMC Cancer; 2017 Jan; 17(1):36. PubMed ID: 28068934
[TBL] [Abstract][Full Text] [Related]
3. A 115-bp MethyLight assay for detection of p16 (CDKN2A) methylation as a diagnostic biomarker in human tissues.
Zhou J; Cao J; Lu Z; Liu H; Deng D
BMC Med Genet; 2011 May; 12():67. PubMed ID: 21569495
[TBL] [Abstract][Full Text] [Related]
4. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
[TBL] [Abstract][Full Text] [Related]
5. Modes of silencing of p16 in development of esophageal squamous cell carcinoma.
Tokugawa T; Sugihara H; Tani T; Hattori T
Cancer Res; 2002 Sep; 62(17):4938-44. PubMed ID: 12208744
[TBL] [Abstract][Full Text] [Related]
6. [Methylation of p16 and hMLH1 genes in esophageal squamous cell carcinoma and reflux esophagitis].
Wang F; Xie XJ; Piao YS; Liu B; Wang LD
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):537-41. PubMed ID: 22169643
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma.
Adams L; Roth MJ; Abnet CC; Dawsey SP; Qiao YL; Wang GQ; Wei WQ; Lu N; Dawsey SM; Woodson K
Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of p16 methylation in Barrett's carcinogenesis.
Chueca E; Valero A; Hördnler C; Puertas A; Carrera P; García-González MA; Strunk M; Lanas A; Piazuelo E
Ann Diagn Pathol; 2020 Aug; 47():151554. PubMed ID: 32570024
[TBL] [Abstract][Full Text] [Related]
9. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
[TBL] [Abstract][Full Text] [Related]
10. Concordance of tumor infiltrating lymphocytes, PD-L1 and p16 expression in small biopsies, resection and lymph node metastases of oropharyngeal squamous cell carcinoma.
Brcic I; Gallob M; Schwantzer G; Zrnc T; Weiland T; Thurnher D; Wolf A; Brcic L
Oral Oncol; 2020 Jul; 106():104719. PubMed ID: 32335324
[TBL] [Abstract][Full Text] [Related]
11. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
[TBL] [Abstract][Full Text] [Related]
12. [Significance of methylation and abnormal expression of p16 gene in endometrial carcinoma].
Yuan JR; Fu SB; Fu H; Li P
Yi Chuan Xue Bao; 2004 May; 31(5):454-9. PubMed ID: 15478604
[TBL] [Abstract][Full Text] [Related]
13. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma.
Abbaszadegan MR; Raziee HR; Ghafarzadegan K; Shakeri MT; Afsharnezhad S; Ghavamnasiry MR
Int J Gastrointest Cancer; 2005; 36(1):47-54. PubMed ID: 16227635
[TBL] [Abstract][Full Text] [Related]
14. [DNA methylation status of RARβ2 and p16(INK4α) in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma].
Wang CC; Mao WM; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):441-5. PubMed ID: 22967446
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
16. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations.
Hardie LJ; Darnton SJ; Wallis YL; Chauhan A; Hainaut P; Wild CP; Casson AG
Cancer Lett; 2005 Jan; 217(2):221-30. PubMed ID: 15617840
[TBL] [Abstract][Full Text] [Related]
17. Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study.
Sun Y; Deng D; You WC; Bai H; Zhang L; Zhou J; Shen L; Ma JL; Xie YQ; Li JY
Clin Cancer Res; 2004 Aug; 10(15):5087-93. PubMed ID: 15297411
[TBL] [Abstract][Full Text] [Related]
18. DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients.
Laytragoon-Lewin N; Chen F; Castro J; Elmberger G; Rutqvist LE; Lewin F; Turesson I; Lundgren J
Anticancer Res; 2010 Nov; 30(11):4643-8. PubMed ID: 21115918
[TBL] [Abstract][Full Text] [Related]
19. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
20. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
